Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer.
A FinelliM KomisarenkoL J MartinN TimilshinaK JainJ MorrisA ZlottaG KulkarniN PerlisTheodorus H Van der KwastA EvansSangeet GhaiN FleshnerS M H AlibhaiR J HamiltonPublished in: Prostate cancer and prostatic diseases (2020)
Use of 5ARIs diminished both grade and volume progression without an increased risk of developing Grade Groups 4-5 disease.